ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but ...

AWS’s robust growth, especially in AI and cloud services, strengthens Amazon’s revenue and positions it as cloud ...

Good afternoon, and thank you for joining us for Remitly's third-quarter 2024 earnings call. Joining me on the call today are ...

These metrics exclude items such as stock-based compensation ... medium and long-term horizons. We have multiple growth ...

We believe Jyothy Labs has come a long way by innovating products across categories, investing in advertisements & ...

Operator: Good day, and welcome to the Third Quarter 2024 Pacira Biosciences Inc. Earnings Conference Call. At this time, all ...

Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

Change Arrows Up And Down.This royalty free vector illustration features the main icon ... dots and point. Digital data planet design in flat style. stock market black and white stock illustrations ...